The truth about the safety of sleeping pills: video report

9 April 2006

Disturbed sleep is one of the most common complaints in medicine. In fact, according to the US National Sleep Foundation, approximately 75% of adults report experiencing sleep problems, which have caused many to rely on sleep medication for help, according to a video report from King Pharmaceuticals.

Since several stories appeared in the US daily the New York Times and on television stations around the country - highlighting concerning side effects associated with sleep medications, including short-term memory loss, binge eating and sleep driving - many Americans may be left with confusing information, leading them to wonder about their safety.

The report claims that sleep deprivation costs an estimated $45.0 billion a year in lost productivity, health care bills and expenses related to traffic accidents; and fatigue plays a role in over 100,000 police-reported highway accidents, leading to 1,500 deaths each year in the USA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight